AMTM
Q3 2026 EPS Estimate
$0.62
Aug 4, 2026 · Reports before open
Revenue Estimate
$3.57B
FY2026E EPS$2.42
FY2027E EPS$2.76

Analyst Sentiment

Wall St. Consensus
Buy
10 analysts·Moderate coverage
63
Score
5 Buy (50%)5 Hold (50%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
550%
Hold
550%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$28.00
+31.8%
Consensus
$35.00
+64.8%
Bull
$37.00
+74.2%
12-Month Target Range10 analysts
$28.00$35.00$37.00
Current $21.24Consensus
Current Price
$21.24
Upside to Consensus
$13.76

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+3.69%
EPS+14.35%
FY2028
Rev+3.83%
EPS+12.92%
FY2029
Rev+5.94%
EPS+7.38%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$14.14B$14.66B$15.22B$16.12B$16.79B
Low$14.09B$14.60B$15.22B$15.98B$16.65B
High$14.20B$14.70B$15.22B$16.26B$16.93B
EBITDA Avg$864M$896M$931M$986M$1.03B
Low$861M$893M$931M$977M$1.02B
High$868M$899M$931M$994M$1.04B
EBIT Avg$414M$429M$445M$472M$491M
Low$412M$427M$445M$467M$487M
High$415M$430M$445M$476M$495M
Net Income Avg$590M$678M$767M$817M$878M
Low$580M$646M$641M$808M$868M
High$599M$710M$893M$826M$888M
EPS Avg$2.42$2.76$3.12$3.35$3.60
Low$2.38$2.65$2.63$3.31$3.56
High$2.46$2.91$3.66$3.39$3.64
Analysts (Rev / EPS)8 / 78 / 710 / 55 / 25 / 2
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028Q3 2028
Revenue Avg$3.86B$3.40B$3.59B$3.68B$3.94B$3.53B$3.72B$3.81B
Low$3.82B$3.34B$3.53B$3.62B$3.88B$3.48B$3.66B$3.75B
High$3.89B$3.45B$3.64B$3.73B$4.00B$3.58B$3.77B$3.86B
EBITDA Avg$236M$208M$220M$225M$241M$216M$227M$233M
Low$233M$205M$216M$221M$237M$213M$224M$229M
High$238M$211M$223M$228M$244M$219M$231M$236M
EBIT Avg$113M$99M$105M$108M$115M$103M$109M$111M
Low$112M$98M$103M$106M$113M$102M$107M$110M
High$114M$101M$106M$109M$117M$105M$110M$113M
Net Income Avg$165M$145M$160M$168M$191M$178M$187M$200M
Low$160M$142M$157M$165M$187M$174M$183M$196M
High$172M$148M$163M$171M$194M$181M$191M$204M
EPS Avg$0.67$0.59$0.65$0.69$0.78$0.73$0.76$0.82
Low$0.65$0.58$0.64$0.67$0.76$0.71$0.75$0.80
High$0.70$0.60$0.67$0.70$0.79$0.74$0.78$0.83
Analysts (Rev / EPS)6 / 63 / 23 / 23 / 23 / 22 / 32 / 32 / 3

Earnings Surprises

Recent Analyst Actions

May 13, 2026RBC Capital
Amentum price target lowered to $28 from $35 at RBC Capital
Target:$28.00
+23.0%from $22.77
May 12, 2026Truist Financial
Amentum price target lowered to $35 from $42 at Truist
Target:$35.00
+40.5%from $24.91
Jan 15, 2026UBS
Amentum price target raised to $37 from $33 at UBS
Target:$37.00
+6.7%from $34.66
Jan 14, 2026Truist Financial
Amentum price target raised to $42 from $34 at Truist
Target:$42.00
+22.4%from $34.30
Dec 3, 2025BTIG
Amentum price target raised to $35 from $30 at BTIG
Target:$35.00
+21.9%from $28.72
Dec 2, 2025Cantor Fitzgerald
Amentum price target raised to $40 from $35 at Cantor Fitzgerald
Target:$40.00
+41.8%from $28.21
Nov 26, 2025Truist Financial
Amentum price target raised to $34 from $30 at Truist
Target:$34.00
+12.3%from $30.27
Nov 26, 2025RBC Capital
Amentum Holdings Inc. (AMTM) PT Raised to $30 at RBC Capital
Target:$30.00
+2.3%from $29.33
Nov 26, 2025JMP Securities
Amentum price target raised to $35 from $30 at Citizens JMP
Target:$35.00
+16.6%from $30.01
Nov 26, 2025Morgan Stanley
Amentum upgraded to Equal Weight from Underweight at Morgan Stanley
Target:$35.00
+16.7%from $30.00
Nov 19, 2025UBS
Amentum initiated with a Neutral at UBS
Target:$25.00
-2.0%from $25.52
Sep 18, 2025Morgan Stanley
Amentum price target raised to $20 from $19 at Morgan Stanley
Target:$20.00
-9.9%from $22.20
Aug 18, 2025Raymond James
Amentum's SFRC award adds 'healthy dose' of visibility, says Raymond James
Target:$30.00
+19.4%from $25.13
May 21, 2025RBC Capital
Amentum price target raised to $24 from $22 at RBC Capital
Target:$24.00
+16.2%from $20.65
Apr 16, 2025Morgan Stanley
Amentum initiated with an Underweight at Morgan Stanley
Target:$19.00
+1.6%from $18.70
Apr 14, 2025Truist Financial
Amentum price target lowered to $24 from $31 at Truist
Target:$24.00
+29.7%from $18.50
Oct 14, 2024Truist Financial
Truist Securities Starts Amentum Holdings Inc. (AMTM) at Buy
Target:$31.00
+15.2%from $26.90
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.